EFNB2 and breast cancer: Barneh et al. stimulated MDA-MB-231 BC cells by diverse concentrations of pre-clustered ephrin-B2-Fc, and underlined a dose-dependent, EPHB4-mediated TNBC growth inhibition after six days, with the cells being in a post-confluent state [46].